Willow Biosciences Inc. (TSX:WLLW)
0.0350
-0.0050 (-12.50%)
May 22, 2025, 2:26 PM EDT
Willow Biosciences Company Description
Willow Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States.
The company has licensing and development partnership with Laurus Labs to develop and commercialize active pharmaceutical ingredients and other ingredients.
Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.
Willow Biosciences Inc.

Country | Canada |
Founded | 2019 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 19 |
CEO | Travis Doupe |
Contact Details
Address: 202, 1201-5th Street SW Calgary, Alberta T2R 0Y6 Canada | |
Phone | 403-910-5140 |
Website | willowbio.com |
Stock Details
Ticker Symbol | WLLW |
Exchange | Toronto Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CAD |
ISIN Number | CA97111B4047 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Travis Doupe | Chief Financial Officer and Interim Chief Executive Officer |
Sanjib Singh Gill L.L.B. | Corporate Secretary |